News
-
-
-
-
-
PRESS RELEASE
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Nyxoah presents DREAM Study results at the International Surgical Sleep Society 2024 Educational Update, showing significant improvements in OSA patients treated with Genio neuromodulation therapy -
-
-
PRESS RELEASE
Very strong support of Atos SE’ shareholders and financial creditors meeting as classes of affected parties vote on the draft accelerated safeguard plan
Atos SE receives strong support from shareholders and creditors for accelerated safeguard plan, with all classes of affected parties voting in favor. Plan to be presented to court on October 15, 2024 -
-
PRESS RELEASE
POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)
POP Biotechnologies and EuBiologics announce positive findings of ECV-19 COVID-19 vaccine in Phase 3 trial in the Philippines, demonstrating safety, immunogenicity, and potential against Omicron variant
